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Isolation of a Yersinia enterocolitica biotype
1B strain in France, and evaluation of its
genetic relatedness to other European and
North American biotype 1B strains
Cyril Savin1, Anne-Sophie Le Guern1, Matthieu Lefranc2, Sylvie Brémont1, Elisabeth Carniel1 and Javier Pizarro-Cerdá1
Yersinia enterocolitica, a member of the Enterobacter-
iaceae family, is a gastrointestinal pathogen. This species
is transmitted via the fecal-oral route, usually through the
consumption of contaminated food, and less often
through direct contact with infected animals1. Y. enter-
ocolitica infections cause diarrhea, fever, and abdominal
pain, mimicking appendicitis, and predominate in chil-
dren2. The species Y. enterocolitica is subdivided into six
biotypes: the nonpathogenic biotype 1A, low-
pathogenicity biotypes 2–5, which cause self-limiting
infections, and the highly pathogenic biotype 1B, which
is more commonly associated with systemic
dissemination3,4.
While biotype 4 is now predominant in North Amer-
ica1,5, biotype 1B was responsible for most of the
Y. enterocolitica infections in the USA until the end of the
1980s5,6. The first outbreak due to Y. enterocolitica 1B was
reported in the state of New York, USA, in 1976, with
more than 200 children and school employees infected
after the consumption of contaminated chocolate milk,
resulting in hospitalization of 36 children7. Other out-
breaks were reported in 1981, 1982, and 1995, due to the
consumption of powder milk, tofu, or Pasteurized milk1.
Y. enterocolitica biotype 1B strains have rarely been
isolated in Europe. In the past 20 years, only two clinical
strains of this biotype have been isolated in France among
a total of 9442 Yersinia strains characterized by the
French National Reference Laboratory, with the last one,
isolated from a clinical cutaneous abscess, dating to 2004
(unpublished data). In Italy, five biotype 1B strains were
isolated between 1979 and 19898, and in Germany, the
first isolation was reported in 20029, but no isolations
have been reported in these countries since then. On the
other hand, the first Y. enterocolitica 1B strain in Poland
was isolated in 2004 from a patient who suffered from
liver cirrhosis10, and the number of isolated strains has
dramatically increased since then11,12. Owing to the sys-
temic dissemination potential of Y. enterocolitica 1B
strains, their spread may cause a serious public health
threat, thus rendering their surveillance crucial.
Herein, we report the case of Y. enterocolitica 1B
infection in a French patient, as well as the characteriza-
tion of the strain and genomic analysis of its genetic
relatedness to other biotype 1B strains.
The case
Here, we report the case of a French 42-year-old woman
who presented with chronic diarrhea, abdominal pain, and
vomiting in August 2017. No history of travel outside
metropolitan France in the last 6 months was reported. She
was treated with ciprofloxacin for 7 days. Subsequently, the
patient developed inflammatory bowel disease, and a
colonoscopy revealed terminal ileitis, a hallmark of enteric
yersiniosis13. Collected stools were semiliquid and glairy,
and their microscopic examination revealed the presence
of rare leukocytes but no erythrocytes, suggesting a bac-
terial infection. A stool sample was seeded on cefsulodin
irgasan novobiocin (CIN) agar medium (Biomérieux, Cat.
#43421, Craponne, France), and incubated for 48 h at 30 °C.
Few Yersinia-like colonies grew, and a Y. enterocolitica
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strain was identified by mass spectrometry (MALDI-TOF,
Bruker Microflex, BDD 6903 MSP) with a score of 2.37.
The strain was sent to the French Yersinia National
Reference Laboratory (Institut Pasteur, Paris, France),
where tests using API20E and 50CH strips, Tween-ester-
ase, pyrazinamidase activity, and O-antigen seroagglutina-
tion revealed that the strain (IP39285) belonged to the Y.
enterocolitica bioserotype 1B/O:7,8-8-8,19. Since isolation
of biotype 1B strains is extremely rare in France, poly-
merase chain reaction (PCR), targeting yadA (located on
the Yersinia virulence plasmid) and fyuA (located in the
Yersinia high-pathogenicity island), was performed. Both
PCR tests were positive, confirming that IP39285 was a
highly pathogenic biotype 1B strain. Multilocus sequence
analysis (glnA, gyrB, hsp60, and recA)14 showed that this
strain belonged to the same branch as other biotype 1B
strains (data not shown). Antimicrobial susceptibility test-
ing, based on the 2017 EUCAST guidelines, revealed
resistance of IP39285 to amoxicillin, as usually observed for
Y. enterocolitica 1B strains, and its susceptibility to all other
antibiotics tested (amoxicillin-clavulanic acid, cephalexin,
cefoxitin, ceftriaxone, ciprofloxacin, nalidixic acid, tri-
methoprim, sulfonamide, tetracycline, and ticarcillin).
We next evaluated the genetic relatedness of IP39285 to
three other biotype 1B strains of French, Belgian, and
USA origin previously isolated at the Yersinia National
Fig. 1 A minimal spanning tree of 19 Y. enterocolitica biotype 1B strains compared with wgSNP analysis using Bionumerics 7.6 (Applied
Maths, Sint-Martens-Latem, Belgium). Numbers on the branches indicate the difference in SNPs between two strains. Logarithmic scaling was
used for branch lengths
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Reference Laboratory, and to 16 biotype 1B strains of
Belgian, German, USA and unknown origin, whose
genomic sequences are publicly available (see Supple-
mentary Table). Whole-genome sequencing of strains
IP39285, IP28308, IP35698, and IP38642 was performed
using a NextSeq® 500 sequencing system (Illumina, San
Diego, CA, USA). The annotated genome of the
IP39285 strain was deposited to GenBank, and is available
under BioProject PRJNA407758 (accession number
NWMR00000000). The genome was annotated with the
NCBI Prokaryotic Genome Annotation Pipeline (PGAP),
and consists of 4,325,608 bp in 143 contigs, with a G+C
content of 47.5%. PGAP found a total of 4061 genes, 3988
coding sequences (CDSs), 73 RNA genes, and 169 pseu-
dogenes. The G+C content and the number of CDSs are
similar to those of other publicly available genomes of
biotype 1B Y. enterocolitica strains. In silico genomic
analysis revealed the presence of classic virulence genes,
including ail, inv, ystA, and myfA, located on the chro-
mosome; fyuA and irp2, located in the Yersinia high-
pathogenicity island; and yadA and virF, located on the
Yersinia virulence plasmid. Prediction of antimicrobial
susceptibility genes in the IP39285 genome using ResFinder
(http://www.genomicepidemiology.org/) allowed the iden-
tification of the blaA gene, responsible for beta-lactam
resistance, as in all other biotype 1B strains, and of the vatF
gene, responsible for streptogramin B resistance, as in 14
out of the 18 other biotype 1B genomes tested.
We then conducted a comparative genomic analysis to
identify single-nucleotide polymorphisms (SNPs) with the
wgSNP analysis module of Bionumerics 7.6 (Applied
Maths, Sint-Martens-Latem, Belgium) using the genome of
strain 8081 as a reference (accession number AM286415)
(Fig. 1). In total, 25,671 SNP positions were identified in the
19 compared strains, highlighting a high genetic diversity
among these isolates (Fig. 1). For comparison, in 264 Y.
enterocolitica biotype 4 strains with no epidemiological
links isolated worldwide in the past 30 years, only 9827
SNPs were identified (data not shown). This diversity was
also observed using a pairwise comparison with numerous
branches, whose length was more than 1000 SNPs. Despite
this diversity, we identified a cluster of six highly homo-
geneous strains (maximum difference of approximately 100
SNPs), which included IP39285. Within this cluster, a
Belgian strain, IP38642, and German strains, SZ506/04,
SZ375/34, and SZ5108/01, had fewer than 18 SNPs, indi-
cating that the strains were highly related to each other.
The USA strain Y286 had only a 37-SNP difference from
the German strain SZ375/04, despite their geographical
distance. The closest relative to the French strain IP39285
was the Y286 strain, with a 95-SNP difference. Other
European and North American strains were distant from
the Y286 strain, with at least 2356 SNP difference.
Altogether, analysis of the cluster including strain
IP39285 and of the other, more distant branches sug-
gested potential circulation of Y. enterocolitica biotype 1B
strains between North America and Europe. We were also
able to detect the microevolution of a Y. enterocolitica
biotype 1B clone settled in Europe, including Belgian and
German strains. Considering the recent increase in Y.
enterocolitica biotype 1B infections in some European
countries, our results highlight the need for more sus-
tained surveillance of this highly pathogenic strain, whose
spread may pose a global public health threat.
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